References
- Biggerstaff, K.D. and Wooten, J.S. (2004). Understanding lipoproteins as transporters of cholesterol and other lipids. Adv. Physiol. Edu. 28: 105–106.
- Kaur, J., Singh, P., Sowers, J.R. (2002). Diabetes and cardiovascular diseases. Am. J. Ther. 9: 510–515.
- Tourlouki, E., Matalas, A.L., Panagiotakos, D.B. (2009). Dietary habits and cardiovascular disease risk in middle-aged and elderly populations: a review of evidence. Clin. Interv. Aging. 4: 319–330.
- Mahdy, A.K., Wonnerth, A., Huber, K., Wojta, J. (2012). Cardiovascular disease risk reduction by raising HDL cholesterol-current therapies and future opportunities. Brit. J. Pharmacol. 167(6): 1177–1194.
- Eckel, R.H., Kahn, R., Robertson, R.M., Rizza, R.A. (2006). Preventing cardiovascular disease and diabetes: a call to action from the American diabetes association and the American heart association. Diabetes. Care. 29(7): 1697–1699.
- Ali, M.K., Bullard, K.M., Imperatore, G., Barker, L., Gregg, E.W. (2012). Characteristics associated with poor glycemic control among adults with self-reported diagnosed diabetes-National health and nutrition examination survey, United States, 2007–2010.MMWRMorbMortal Wkly Rep. 61(2): 32-37.
- Celermajer, D.S., Chow, C.K., Marijon, E., Anstey, N.M., Woo, K.S. (2012). Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection. J. Amer. Coll. Cardiol. 60(14): 1207–1216.
- Hanukoglu, I., Steroidogenic., 1992. Enzymes: structure, function, and role in regulation of steroid hormone biosynthesis. J. Steroid. Biochem. Mol. Biol. 43: 779-804.
- Robert, K.M., Daryl, K.G., Peter, A.M., Victor, W.R. (2003). Cholesterol synthesis, transport and excretion. Peter A.Mayes, Kathleen M.Botham. 26th ed. Mc Graw Hill, 219-241.
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evalua- tion, and Treatment of High Blood Cholesterol in Adults. (1998). The Expert Panel. Arch. Intern. Med. 148: 36–69.
- Brunzell, J.D., Davidson, M., Furberg, C.D., Goldberg, R.B., Howard, B.V., Stein, J.H., Witztum, J.L., (2008). Lipoprotein management in patients with cardio metabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care. 31: 811–822.
- Cardiovascular Diseases, WHO. Link: https://www.afro.who.int/health-topics/cardiovascular- diseases
- WHO Report, (2012). World Health statistics. World Health Organization. Retrieved on 16 September 2018. http://www.who.int/gho/publications/world-health-statistics/EN-WHS2012-Full.pdf
- Kirby, T.J. (1967). Cataracts produced by triparanol. (MER-29). Trans. Amer. Ophthalmol. Soc. 65: 494–543.
- Endo, A., Kuroda, M., Tsujita, Y. (1976). ML-236A, ML-236B and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum. J. Antibiot. 29: 1346–1348.
- Vagelos, P.R. (1991). Are prescribing drug prices high? Sci. 252: 1080-1084.
- Vagelos, P.R., Galambos, L. (2004). Medicine, Science and Merck. Cambridge University Press, Cambridge, United Kingdom. pp. 1-301.
- Subazini, T.K., Kumar, G.R. (2011). Characterization of Lovastatin biosynthetic cluster proteins in Aspergillus terreus strain ATCC 20542. Bioinformat. 6: 250–254.
- Manzoni, M., Rollini, M. (2002). Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Appl. Microbiol. Biotechnol. 58: 555–564.
- MEVACOR™ Daily Tablets. (2018). (Nonprescription lovastatin 20 mg). Available online: http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4331b1-02-Merck.pdf (accessed on 16 September 2018).
- Crain’s New York Business via Associated Press. (2018). Lipitor becomes world’s top-selling drug. 28 December 2011. Retrieved 16 September 2018.
- Van ven Berg, M.A., Hans, M. (2011). Improved statin production. US 20110223640 A1, 2011.
- Hutchinson, C.R., Kennedy, J., Park, C. (2005). Transforming the organism (lovastatin pro- ducing 1362 organism) with the D4B segment of Aspergillus terreus, wherein the segment is transcribed and translated, and wherein an increase in lovastatin production occurs. US 1364 6943017 B2, 2005.
- Hajjaj, H., VanDen, B.P., Niederberger, P., Fay, L.B., Mace, C., Neeser, J.R. (2003). Koji molds for preparing cholesterol lowering products. US20030133920 A1, 2003.
- Hong, S.T., Kim, H.J., Lee, D.K., Yang, W.Y. (2003). Adding a microbial culture of a fermentation medial containing an anticholesterol agent to animal feed. US20030194394 A1, 2003.
- Vanven, B.M.A., Hans, M., Streekstra, H. (2009). Method for the production of simvastatin. US 20090197311 A1, 2009.
- Dimov, D.I., Grozdanov, G.A., Petkov, N.G., Todorova, D.T., Dimitrova, A.S. (1997). Method of production of lovastatin. WO1997020834, 1997.
- Hajko, P., Vesel, T., Radez, I., Pokorny, M. (1994). Process for the isolation of lovastatin. WO 199429292, 1994.
- Kumar, P.M., Mitra, A., Malviya, H.K. (2006). Process for the purification of lovastatin. WO 2006035295 A1, 2006.
- Jakubcova, M., Bosansky, M., Lucina, B., Borosova, G. (2000). Process for the isolation of lovastatin from fermentation broth. WO2000063411, 2000.
- Keri, V., Deak, L., Forgacs, I., Szabo, C., Nagyne, E.A. (2001). Process for recovering statin compounds from a fermentation broth. WO2001039768 A1, 2001.
- Huang, C.F. (2007). Effect of Monascus purpureus went rice on lowering lipid ratios in hyper- cholesterolemic patients. Eurp. J. Cardiovasc. Prev. Rehabil. 14(3): 438–440.
- Becker, D.J., Gordon, R.Y., Halbert, S.C., French, B., Morris, P.B., Rader, D.J. (2009). Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Ann. Int. Med. 150: 830-839.
- Stossel, T.P. (2008). The discovery of statins. Cell. 134: 903–905.
- Tobert, J.A. (2003). Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. Nat. Rev. Drug. Discov. 2(7): 517–26.
- Endo, A., Monacolin, K. (1979). A new hypocholesterolemic agent produced by a monascus species. J. Antibiot. 32: 853–854.
- Sayyad, S.A., Panda, B.P., Javed, S., Ali, M. (2007). Optimization of nutrient parameters for lovastatin production by Monascus purpureus MTCC 369 under submerged fermentation using response surface methodology. Appl. Microbiol. Biotechnol. 73(5): 1054–8.
- Wang, J.J., Lee, C.L., Pan, T.M. (2003). Improvement of monacolin K, -aminobutyric acid and citrinin production ratio as a function of environmental conditions of Monascus purpureus NTU 601. J. Ind. Microbiol. Biotechnol. 30: 669–676.
- Porcel, E.R., Lopéz, J.L., Ferron, M.A., Perez, J.A., Sanchez, J.L., Chisti, Y. (2006). Effects of the sporulation conditions on the lovastatin production by Aspergillus terreus. Bioproc. Biosyst. Eng. 29(1): 1–5.
- Hajjaj, H., Niederberger, P., Duboc, P. (2001). Lovastatin biosynthesis by Aspergillus terreus in a chemically defined medium. Appl. Environ. Microbiol. 67(6): 2596-2602.
- Valera, H.R., Gomesa, J., Lakshmib, S., Gururajab, R., Suryanarayanb, S., Kumar, D. (2005). Lovastatin production by solid state fermentation using Aspergillus flavipes. Enz. Microb. Technol. 37(5): 521-526.
- Samiee, S.M., Moazami, N., Haghighi, S., Mohseni, F.A., Mirdamadi, S., Bakhtiari, M.R. (2003). Screening of lovastatin production by filamentous fungi. Iran. Biomed. J. 7(1): 29–33.
- Sreenivasan, A., Shubahgar, S., Arvindan, R., Viruthagiri, T. (2008). Microbial production and biomedical applications of lovastatin. Ind. J. Pharm. Sci. 70(6): 701–709.
- Barrios-González, J., Miranda, R.U. (2009). Biotechnological production and applications of statins. Appl. Microbiol. Biotechnol. 85: 869–883.
- Istvan, E. (2003). Statin inhibition of HMG-CoA reductase: A 3-dimensional view. Atheroscler. Suppl. 4: 3–8.
- Bizukojc, M.; Pecyna, M. (2011). Lovastatin and (+)-geodin formation by Aspergillus terreus ATCC 20542 in a batch culture with the simultaneous use of lactose and glycerol as carbon sources. Eng. Lif. Sci. 11: 272–282.
- Lai, L.S., Hung, C.S., Lo, C.C. (2007). Effects of lactose and glucose on production of itaconic acid and lovastatin by Aspergillus terreus ATCC 20542. J. Biosci. Bioeng. 104(1): 9-13
- Lopéz, J.L.C., Pérez, J.A.S., Sevilla, J.M.F., Fernández, F.G.A., Grima, E.M., Chisti, Y. (2003). Production of lovastatin by Aspergillus terreus: effects of the C: N ratio and the principal nutrients on growth and metabolite production. Enz. Microb. Technol. 33(2-3): 270–307.
- Lopéz, J.L.C., Perez, J.A.S., Sevilla, J.M.F., Fernandez, F.G.A., Grima, E.M., Chisti, Y. (2003). Production of lovastatin by Aspergillus terreus: effects of the C: N ratio and the principal nutrients on growth and metabolite production. Enz. Microb. Technol. 33: 270–307.
- Lai, L.S.T., Tsai, T.R., Wang, T.C., Cheng, T.Y. (2005). The influence of culturing environments on lovastatin production by Aspergillus terreus in submerged cultures. Enz. Microb. Technol. 36: 737–748.
- Kumar, M.S., Jana, S.K., Senthil, V., Shashanka, V., Kumar, S.V., Sadhukhan, A.K. (2000b). Repeated fed-batch process for improving lovastatin production. Proc. Biochem. 36: 363–368.
- Gupta, K., Mishra, P.K., Srivastava, P. (2007). A correlative evaluation of morphology and rheology of Aspergillus terreus during lovastatin fermentation. Biotechnol. Bioproc. Eng. 12: 140–146.
- Lopéz, J.L.C., Perez, J.A.S., Sevilla, J.M.F., Porcel, E.M.R., Chisti, Y. (2005). Pelletmorpho- logy, culture rheology and lovastatin production in cultures of Aspergillus terreus. J. Biotechnol. 116(1): 61–77.
- Pansuriya, R.C., Singhal, R.S. (2010). Response surface methodology for optimization of pro- duction of lovastatin by solid-state fermentation. Braz. J. Microbiol. 41: 164–72.
- Kavitha, V., Janani, B., Angayarkanni, J. (2012). Optimization of process parameters for lovastatin production from red gram bran by solid-state fermentation. Int. J. Sci. Res. 3: 1413- 1418.
- Osman, M.E., Khattab, O.H., Zaghlol, G.M., El-Hameed, R.M.M. (2011a). Optimization of some physical and chemical factors for lovastatin productivity by local strain of Aspergillus terreus. Aust. J. Basic. Appl. Sci. 5(6): 718–732.
- Pawlak, M., Bizukojc, M. (2013). Feeding profile is not the sole factor influencing lovastatin production by Aspergillus terreus ATCC20542 in a continuous fed-batch stirred tank bioreactor. Biochem. Eng. J. 81: 80–89.
- Bizukojc, M., Pawlak, M., Boruta, T., Gonciarz, J. (2012). Effect of pH on biosynthesis of lovastatin and other secondary metabolites by Aspergillus terreus ATCC 20542. J. Biotechnol. 162(2-3): 253–261.
- Li, S.W., Li, M., Song, H.P., Feng, J.L., Tai, X.S. (2011). Induction of a high-yield lovastatin mutant of Aspergillus terreus by 12c6+ heavy-ion beam irradiation and the influence of culture conditions on lovastatin production under submerged fermentation. Appl. Biochem. Biotechnol. 165: 913–925.
- Panda, B.P., Javed, S., Ali, M. (2010). Optimization of fermentation parameters for higher lovastatin production in red mold rice through co-culture of Monascus purpureus and Monascus ruber. Food. Bioproc. Technol. 3(3): 373.
- Syed, M.B., Rajasimman, M. (2015). Fermentative production and optimization of mevastatin in submerged fermentation using Aspergillus terreus. Biotechnol. Rep. 6: 124–128.
- Jahromi, M.F., Liang, J.B., Ho, Y.W., Mohamad, R., Goh, Y.M., Shokryazdan, P. (2012). Lovastatin production by Aspergillus terreus using agro-biomass as substrate in solid state fermen- tation. J. Biomed. Biotechnol. 2012: 1–11.
- Gulyamova, T., Ruzieva, D., Masmetova, S., Sattarova, R., Lobanova, K., Abdulmyanova, L., Rasulova, G. (2013). Lovastatin production by Aspergillus terreus in solid state and submerged fermentations. Int. J. Eng. Sci. Technol. 2013, 5, 19-24.
- Wei, P., Xu, Z., Cen, P. (2007). Lovastatin production by Aspergillus terreus in solid-state fermentation. J. Zhejiang. Uni. Sci. A.8: 1521-1526.
- Patil, R.H., Krishnan, P., Maheshwari, V.L. (2011). Production of lovastatin by wild strains of Aspergillus terreus. Natl. Prod. Commun. 6: 183-186
- Kaur, H., Kaur, A., Saini, H., Chadha, B. (2009). Screening and selection of lovastatin hyper- producing mutants of Aspergillus terreus using cyclic mutagenesis. Acta Microbiol. Immunol. Hung. 56: 169–180.
- Lopéz, J.L.C., Pérez, J.A.S., Sevilla, J.M.F., Fernández, F.G.A., Grima, E.M., Chisti, Y. (2004a). Fermentation optimization for the production of lovastatin by Aspergillus terreus: use of response surface methodology. J. Chem. Technol. Biotechnol. 79(10): 1119–26.
- Sorrentino, F., Roy, I., Keshavarz, T. (2010). Impact of linoleic acid supplementation on lovastatin production in Aspergillus terreus cultures. Appl. Microbiol. Biotechnol. 88(1): 65–73.
- Jia, Z., Zhang, X., Zhao, Y., Cao, X. (2010). Enhancement of lovastatin production by supple- menting polyketide antibiotics to the submerged culture of Aspergillus terreus. Appl. Biochem. Biotechnol. 160(7): 2014-25.
- Jia, Z., Zhang, X., Cao, X. (2009). Effects of carbon sources on fungal morphology and lovastatin biosynthesis by submerged cultivation of Aspergillus terreus. Asia-Pacific J. Chem. Eng. 4: 672-677.
- Jia, Z., Zhang, X., Zhao, Y., Cao, X. (2009). Effects of divalent metal cations on lovastatin biosynthesis from Aspergillus terreus in chemically defined medium. World J. Microbiol. Biotechnol. 25: 1235–1241.
- Porcel, E.M.R., López, J.L.C., Pérez, J.A.S., Chisti, Y. (2008). Lovastatin production by Aspergillus terreus in a two-staged feeding operation. J. Chem. Technol. Biotechnol. 83: 1236-1243.
- Nasmetova, S., Ruzieva, D., Rasulova, G., Sattarova, R., Gulyamova, T. (2015). Effect of the principal nutrients on simvastatin production by wild strain Aspergillus terreus 20 in submerged fermentation. Int. J. Curr. Microbiol. App. Sci. 4: 894–898.
- Abd-Rahim, M.H., Hasan, H., Montoya, A., Abbas, A. (2015). Lovastatin and (+)-geodin production by Aspergillus terreus from crude glycerol. Eng. Life. Sci. 15: 220–228.
- Raina, S., De Vizio, D., Palonen, E.K., Odell, M., Brandt, A.M., Soini, J.T., Keshavarz, T. (2012). Is quorum sensing involved in lovastatin production in the filamentous fungus Aspergillus terreus? Proc. Biochem. 47: 843–852.
- Vinci, V.A., Hoerner, T.D., Coffman, A.D., Schimmel, T.G., Dabora, R.L., Kirpekar, A.C., Ruby, C.L., Stieber, R.W. (1991). Mutants of a lovastatin-hyperproducing Aspergillus terreus deficient in the production of sulochrin. J. Ind. Microbiol. 8: 113–119.
- Ferrón, M.A.V., Lopéz, J.L.C., Perez, J.A.S., Sevilla, J.M.F., Chisti, Y. (2005). Rapid screening of Aspergillus terreus mutants for overproduction of lovastatin. World. J. Microbiol. Biotechnol. 21(2): 123–12.
- Mukhtar, H., Ijaz, S.S., Ikram-ul-Haq. (2014). Upstream and downstream processing of lovas- tatin by Aspergillus terreus. Cell Biochem. Biophys. 70: 309–320.
- Sreedevi, K., Venkateswara, R.J., Lakshmi, N., Fareedullah, M.D. (2011). Strain improvement of Aspergillus terreus for the enhanced production of lovastatin, a HMG-COA reductase inhibitor. J. Microbiol. Biotech. 1: 96–100.
- Jia, Z., Zhang, X., Cao, X., Liu, J., Qin, B. (2011). Production of lovastatin by a self-resistant mutant of Aspergillus terreus. Ann. Microbiol. 61: 615–621.
- Kumar, M.S., Kumar, P.M., Sarnaik, H.M., Sadhukhan, A.K. (2000a). A rapid technique for screening of lovastatin-producing strains of Aspergillus terreus by agar plug and Neurospora crassa bioassay. J. Microbiol. Methods. 40(1): 99–104.
- Slot, J.C., Rokas, A. (2011). Horizontal transfer of a large and highly toxic secondary metabolic gene cluster between fungi. Curr. Biol. 21(2): 134–139.
- Barrios-González, J., Baños, J.G., Covarrubias, A.A., Garay-Arroyo, A. (2008). Lovastatin biosynthetic genes of Aspergillus terreus are expressed differentially in solid-state and in liquid submerged fermentation. Appl. Microbiol. Biotechnol. 79(2): 179–86.
- Chen, Y.P., Tseng, C.P., Liaw, L.L., Wang, C.L., Chen, I.C., Wu, W.J., Wu, M.D., Yuan, G.F. (2008). Cloning and characterization of monacolin K biosynthetic gene cluster from Monascus pilosus. J. Agril. Food. Chem. 56: 5639–5646.
- Kennedy, J., Auclair, K., Kendrew, S.G., Park, C., Vederas, J.C., Hutchinson, C.R. (1999). Modulation of polyketide synthase activity by accessory proteins during lovastatin biosynthesis Amer. Assoc. Adv. Sci. 284(5418): 1368–1372.
- Vanven, B.MA., Hans, M. (2011). Improved statin production. US 20110223640 A1, 2011.
- Vinci, V.A., Conder, M.J., McAda, P.C., Reeves, C.D., Rambosek, J., Davis, C.R., Hendrick- son, L.E. (1998). DNA encoding triol polyketide synthase. US 5744350 A, 1998.
- Xu, W., Chooi, Y.H., Choi, J.W., Li, S., Vederas, J.C., Da Silva, N.A. (2013). LovG: the thio- esterase required for dihydromonacolin L release and lovastatin nonaketide synthase turnover in lovastatin biosynthesis. Angew. Chem. Int. Ed. Engl. 52(25): 6472–6505.
- Burr, D.A., Chen, X.B., Vederas, J.C. (2007). Syntheses of conjugated pyrones for the enzymatic assay of lovastatin nonaketide synthase, an iterative polyketide synthase. Org. Lett. 9(1): 161-164.
- Hendrickson, L., Davis, C.R., Roach, C., Nguyen, D.K., Aldrich, T., McAda, P.C. (1999). Lovastatin biosynthesis in Aspergillus terreus - characterization of blocked mutants, enzyme activities and a multifunctional polyketide synthase gene. Chem. Biol. 6(7): 429–439.
- Mulder, K.C., Mulinari, F., Franco, O.L., Soares, M.S., Magalhaes, B.S., Parachin, N.S. (2015). Lovastatin Production: From Molecular Basis to Industrial Process Optimization. Bio- technol. Adv. 33: 648–665.
- Monaghan, L.R., Alfred, W.A., Carl, H.H., George, Albers, S. (1980). Antilipemic agents; US 4231938 A.
- Wasser, S.P., Reshetnikov, S.V. (2002). Process for producing, methods and compositions of cholesterol-lowering agents from higher basidiomycetes mushrooms. US Patent (6372462), 6: 327–462.
- Song, T.Y., Yen G.C. (2002). Antioxidant properties of Antrodia camphorata in submerged culture. J. Agric. Food. Chem. 50: 3322–3327.
- Asatiani, M.D., Elisashvili, V., Wasser, S.P., Reznick, A.Z., Nevo, E. (2007). Antioxidant acti- vity of submerged cultured mycelium extracts of higher Basidiomycetes mushrooms. Int. J. Med. Mushrooms. 9: 151–58.
- Burcu, A., Eskisehir O., Mustafa, Y. (2012). Screening of Medicinal Higher Basidiomycetes Mushrooms from Turkey for Lovastatin Production, International J. Med. Mushrooms. 14 (2): 149-159.
- Macreadie, I.G., Johnson, G., Schlosser, T., Macreadie, P.I. (2006). Growth inhibition of Candida species and Aspergillus fumigatus by statins. FEMS. Microbiol. Lett. 262: 9–13.
- Shin-Yu, C., Kung-Jui, H., Yun-Jung, H., Li-Ting, W., Jeng-Leun, M. (2012). Contents of lovastatin, -aminobutyric acid and ergothioneine in mushroom fruiting bodies and mycelia. LWT. 47(2): 274–278.
- Alarcon, J., Aguila, S., Arancibia-Avila, P., Fuentes, O., Zamorano-Ponce, E., Hernandez, M. (2003). Production and purification of statins from Pleurotus ostreatus (Basidiomycetes) strains. Z. Naturforsch. C. 58(1-2): 62–64.
- Lee, J.W., Lee, S.M., Gwak, K.S., Lee, J.Y., Choi, I.G. (2006). Screening of edible mushrooms for the production of Lovastatin and its HMG-CoA reductase inhibitory activity. Kor. J. Microbiol. 42: 83–88.
- Lindequist, U., Niedermeyer, T. H. J., Jülich, W.D. (2005). The pharmacological potential of mushrooms. Evid. Compl. Altern. Med. 2: 285–299.
- Cohen, N., Cohen, J., Asatiani, M.D., Varshney, V.K., Yu, H.T., Yang, Y.C., Li, Y.H., Mau, J.L., Wasser, S.P. (2014). Chemical composition and nutritional and medicinal value of fruit bodies and submerged cultured mycelia of culinary-medicinal higher Basidiomycetes mushrooms. Int. J. Med. Mushrooms. 16: 273-291
- Altmaier, E., Fobo, G., Heier, M., Thorand, B., Meisinger, C., Römisch-Margl, W., Walden- berger, M., Gieger, C., Illig, T., Adamski, J., Suhre, K., Kastenmüller, G. (2014). Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism. Eur. J. Epidemiol. 29(5): 325-336
- Subhan, M., Faryal, R., Macreadie, I. (2016). Exploitation of Aspergillus terreus for the production of natural statins, J. Fungi. 2(2): 13.
- Bhargavi, S.D., Praveen, V.K. and Savitha, J., (2014). Bioinformatic comparative analysis of lovastatin gene cluster in endophytic fungi and a soil fungus, Aspergillus terreus, MOJ. Proteom. Bioinform. 1(4): 1–4.
- FAOSTAT. (2014). Available online: http://faostat.fao.org/site/567/DesktopDefault.aspx?PageID=567#ancor (Retrieved on 1-11-2018).